Project Description

Lineage Cell Therapeutics
The Eyes Of The World

Date & Time:

January 14, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event:

Please join us as we host Dr. Rob Rothman, the world’s leading ophthalmology investor, and Brian Culley CEO of Lineage Cell Therapeutics [LCTX] as they speak about opportunities in new technologies for combatting eye disease.

Their in-depth discussion will cover how Lineage uses a proprietary cell-based therapy platform, OpRegen to replace dysfunctional cells or cells that are absent due to degenerative disease or traumatic injury. OpRegen treats the leading cause of irreversible vision loss in the U.S., Dry Age-related Macular Degeneration (Dry AMD) and has been granted Fast Track designation from the FDA.

Sign up to reserve your place for this informative discussion of how Lineage Cell Therapeutics is transforming the treatment of eye disease.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.